NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

The summary for the NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional): This announcement encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

Federal Grant Title:	NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-25-133
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.853
CFDA Descriptions:	Information not provided
Current Application Deadline:	September 5th, 2027
Original Application Deadline:	September 5th, 2027
Posted Date:	November 12th, 2024
Creation Date:	November 12th, 2024
Archive Date:	October 11th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	November 12th, 2024

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-25-133.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not ...; • Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Requ...; • NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Pr...; • Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammato...; • NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required); • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44); • NINDS Institutional Center Core Grants to Support Neuroscience Research; • Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health: • Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clini...; • Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborativ...; • Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical ...; • Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collab...; • Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science ...